<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001033475</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001175151</issuerCik>
        <issuerName>Cytosorbents Corp</issuerName>
        <issuerCusip>23283X206</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>305 COLLEGE ROAD EAST</com:street1>
          <com:city>PRINCETON</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>08540</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>AVENIR CORP</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>VA</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <sharedVotingPower>5230099.00</sharedVotingPower>
        <sharedDispositivePower>5230099.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5230099.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>8.3</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>James H. Rooney</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>VA</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <sharedVotingPower>5230099.00</sharedVotingPower>
        <sharedDispositivePower>5230099.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <classPercent>8.3</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Cytosorbents Corp</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>305 COLLEGE ROAD EAST, PRINCETON, NEW JERSEY, 08540</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13G ("Schedule") is being filed on behalf of Avenir
Corporation ("Avenir"), a Virginia  corporation, and James H.
Rooney (Mr. Rooney along with Avenir are "Reporting Persons").

Avenir is an investment adviser registered under the Investment Advisers Act of
1940, as amended ("Advisers Act").

Mr. Rooney is the portfolio manager and a shareholder of Avenir.
</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>277 South Washington Street
Suite 350
Alexandria, VA 22314</principalBusinessOfficeOrResidenceAddress>
        <citizenship>State of Virginia, USA</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>5,230,099</amountBeneficiallyOwned>
        <classPercent>8.33%</classPercent>
        <numberOfSharesPersonHas>
          <sharedPowerOrDirectToVote>5,230,099</sharedPowerOrDirectToVote>
          <sharedPowerOrDirectToDispose>5,230,099</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>AVENIR CORP</reportingPersonName>
      <signatureDetails>
        <signature>James H. Rooney</signature>
        <title>President</title>
        <date>02/13/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>James H. Rooney</reportingPersonName>
      <signatureDetails>
        <signature>James H. Rooney</signature>
        <title>President</title>
        <date>02/13/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
